跳至主要内容
临床试验/NCT02262481
NCT02262481已完成不适用

A Randomized, Double Blinded, Placebo Controlled Trial of Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
The recurrence of uterine contraction within 48 hours after stop tocolytic

研究概览

简要总结

The purpose of this study is to evaluate the effect of oral progesterone supplementation in preterm labor on the prevention of recurrent uterine contraction and prolonging pregnancy period, and its side effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton pregnancy
  • Preterm labor
  • GA24-34wk
  • Intact membranes

排除标准

  • Maternal/fetal condition requiring immediate delivery ex. Chorioamnionitis, fetal distress
  • Placenta previa
  • medical and obstetric complications
  • allergy to dydrogesterone

研究组 & 干预措施

Dydrogesterone

Active Comparator

tocolytic + corticosteroids + Dydrogesterone 10 mg/tablet prepare in capsule, 1 cap oral every 12 hours, starting form enrollment until gestational age 37 weeks

干预措施: dydrogesterone (Drug)

Placebo

Placebo Comparator

tocolytic + corticosteroids + Placebo prepare in capsule, 1 cap oral every 12 hours, starting form enrollment until gestational age 37 weeks

干预措施: placebo (Drug)

结局指标

主要结局

The recurrence of uterine contraction within 48 hours after stop tocolytic

时间窗: 48 hours

次要结局

  • side effects(9 weeks)
  • Number of newborn with intraventricular hemorrhage(9 weeks)
  • Time from preterm labor pain to delivery(9 weeks)
  • Number of newborn with respiratory distress syndrome(9 weeks)
  • Number of newborn with necrotizing enterocolitis(9 weeks)
  • Number of newborn with sepsis(9 weeks)
  • Gestational age at delivery(9 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vorapong Phupong

Vorapong

Chulalongkorn University

研究点 (1)

Loading locations...

相似试验

Oral Progestogen Supplementation in the Prevention... | 临床试验